(Q38013679)

27 August 2017

title

Novel targets against retinal angiogenesis in diabetic retinopathy (English)

1 reference

27 August 2017

1 reference

Shuang Wang

1

1 reference

27 August 2017

James K Park

series ordinal

2

1 reference

27 August 2017

Elia J Duh

series ordinal

3

1 reference

27 August 2017

publication date

1 August 2012

1 reference

27 August 2017

published in

Current diabetes report

1 reference

27 August 2017

volume

12

1 reference

27 August 2017

issue

4

1 reference

27 August 2017

page(s)

355-363

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-012-0289-0

27 August 2017

exact match

0 references

cites work

The prevalence of diabetic retinopathy among adults in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Treatment of proliferative diabetic retinopathy with anti-VEGF agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Selective and pan-blockade agents in the anti-angiogenic treatment of proliferative diabetic retinopathy: a literature summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Endogenous VEGF is required for visual function: evidence for a survival role on müller cells and photoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The growth hormone hypothesis - 2005 revision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Medical treatment of diabetic retinopathy with somatostatin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

VEGF and angiopoietin signaling in tumor angiogenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Angiopoietin/Tek Interactions Regulate MMP-9 Expression and Retinal Neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Potential role of the angiopoietin/tie2 system in ischemia-induced retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

A human neutralizing antibody specific to Ang-2 inhibits ocular angiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

A novel angiopoietin-derived peptide displays anti-angiogenic activity and inhibits tumour-induced and retinal neovascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Erythropoietin produced by the retina: its role in physiology and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Retinal and choroidal microangiopathies: therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

SDF-1 is both necessary and sufficient to promote proliferative retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Wnt pathway antagonists and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The role of wnt signaling in physiological and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Blocking the Wnt pathway, a unifying mechanism for an angiogenic inhibitor in the serine proteinase inhibitor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Wnt signaling mediates pathological vascular growth in proliferative retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Gene transfer for ocular neovascularization and macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The potential of nanomedicine therapies to treat neovascular disease in the retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Difference in ischemic regulation of vascular endothelial growth factor and pigment epithelium--derived factor in brown norway and sprague dawley rats contributing to different susceptibilities to retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Regulation of angiogenesis in diabetic retinopathy: possible balance between vascular endothelial growth factor and endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Enhanced proangiogenic signaling in thrombospondin-1-deficient retinal endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Thrombospondin-1-deficient mice exhibit increased vascular density during retinal vascular development and are less sensitive to hyperoxia-mediated vessel obliteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The vasohibin family: Novel regulators of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Molecular targets for retinal vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Inhibition of choroidal neovascularization by a peptide inhibitor of the urokinase plasminogen activator and receptor system in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Dynamics of endothelial cell behavior in sprouting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

The Notch signaling pathway in retinal dysplasia and retina vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Axon guidance molecules in vascular patterning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Sema3E-PlexinD1 signaling selectively suppresses disoriented angiogenesis in ischemic retinopathy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Robo4-dependent Slit signaling stabilizes the vasculature during pathologic angiogenesis and cytokine storm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-012-0289-0

Angiogenic pathways in diabetic retinopathy

21 January 2018

1 reference

12 December 2020

Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor

1 reference

12 December 2020

Attenuation of retinal vascular development and neovascularization in transgenic mice over-expressing thrombospondin-1 in the lens

1 reference

12 December 2020

Erythropoietin deficiency decreases vascular stability in mice.

1 reference

12 December 2020

Vitreous levels of vasohibin-1 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy

1 reference

12 December 2020

Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization

1 reference

12 December 2020

Essential role of growth hormone in ischemia-induced retinal neovascularization

1 reference

12 December 2020

Matrix metalloproteinases in diabetic retinopathy: potential role of MMP-9.

1 reference

12 December 2020

The SDF-1/CXCR4 ligand/receptor pair is an important contributor to several types of ocular neovascularization

1 reference

12 December 2020

Long-term Treatment with Suberythropoietic Epo is Vaso- and Neuroprotective in Experimental Diabetic Retinopathy

1 reference

12 December 2020

Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor

1 reference

12 December 2020

Notch signaling in ocular vasculature development and diseases

1 reference

12 December 2020

Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor

1 reference

12 December 2020

Intravitreous levels of hepatocyte growth factor/scatter factor and vascular cell adhesion molecule-1 in the vitreous fluid of diabetic patients with proliferative retinopathy

1 reference

12 December 2020

Mechanisms of hepatocyte growth factor-induced retinal endothelial cell migration and growth

1 reference

12 December 2020

Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema

1 reference

12 December 2020

Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy

1 reference

12 December 2020

1 reference

12 December 2020

10.1007/S11892-012-0289-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1030753613

0 references

1 reference